Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Futures Kickoff
Get prepared for your futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to experience risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit
The Rosen Law Firm is reminding purchasers of Ultragenyx Pharmaceutical Inc. common stock between August 3, 2023, and December 26, 2025, that they have until April 6, 2026, to move for lead plaintiff in a securities fraud lawsuit. The lawsuit alleges that Ultragenyx made misleading statements regarding its Phase III Orbit and Cosmic Studies for setrusumab, which failed to demonstrate a decrease in annualized fracture rates for Osteogenesis Imperfecta patients despite increasing bone density. Investors who bought stock during this period may be entitled to compensation.